BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6782276)

  • 1. [Study on factor VIII complex in 106 cases of liver disease (author's transl)].
    Aihara M; Sawada Y; Kimura A; Chiba Y; Yoshida Y
    Rinsho Ketsueki; 1980 Nov; 21(11):1655-63. PubMed ID: 6782276
    [No Abstract]   [Full Text] [Related]  

  • 2. [Electrophoretic properties of the factor VIII/vW complex in liver disease (author's transl)].
    Vicente García VU; Alberca Silva I; Moraleda Jiménez JM; López Borrasca A
    Sangre (Barc); 1980; 25(4):471-8. PubMed ID: 6775380
    [No Abstract]   [Full Text] [Related]  

  • 3. [Application if different techniques to the diagnosis of von Willebrand's disease (author's transl)].
    Solana JM; Rocha E; Arrizabalaga B; López A; Febres R; Fernández J
    Sangre (Barc); 1981; 26(6):1156-63. PubMed ID: 6805084
    [No Abstract]   [Full Text] [Related]  

  • 4. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease.
    Böhm M; Täschner S; Kretzschmar E; Gerlach R; Favaloro EJ; Scharrer I
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):39-45. PubMed ID: 16607078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Factor VIII (coagulation activity VIII:C, antigen concentration VIIIR:Ag and von Willebrand factor) in patients with clinically expected intravascular coagulation].
    Tran TH; Lämmle B; Marbet UA; Ritz R; Marbet GA; Duckert F
    Schweiz Med Wochenschr; 1981 Oct; 111(41):1542-3. PubMed ID: 6797063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis of Von Willebrand's syndrome (author's transl)].
    Hariga-Muller C; Capel P; De Maertelaere-Laurent E; Masramon AM; Fondu P
    Rev Med Brux; 1981 Mar; 2(3):245-50. PubMed ID: 6785854
    [No Abstract]   [Full Text] [Related]  

  • 7. [Blood coagulation factor VIII complex in liver diseases].
    Mizuguchi A
    Nihon Shokakibyo Gakkai Zasshi; 1985 Jun; 82(6):1533-42. PubMed ID: 2932577
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of factor VIII complex in increased VIII:Ag cases].
    Iijima K; Kuranobu M; Fukuda C; Nakamura K
    Rinsho Byori; 1986 Apr; 34(4):459-63. PubMed ID: 3091887
    [No Abstract]   [Full Text] [Related]  

  • 9. [The factor VIII complex: hemophilia A and von Willebrand disease (author's transl)].
    Tobelem G; Rothschild C
    Ann Pediatr (Paris); 1982 Feb; 29(2):95-9. PubMed ID: 6800297
    [No Abstract]   [Full Text] [Related]  

  • 10. [Factor VIII:C and factor VIII:Ag in liver diseases].
    Procházka J; Hauftová D; Fischerová E; Smrcková H
    Cesk Gastroenterol Vyz; 1983 Nov; 37(6-7):364-72. PubMed ID: 6418392
    [No Abstract]   [Full Text] [Related]  

  • 11. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism.
    Hari P; Prasad Chemiti GK; Lankipalli RS
    N Engl J Med; 2000 Dec; 343(26):1968-9. PubMed ID: 11186673
    [No Abstract]   [Full Text] [Related]  

  • 12. Acquired Von Willebrand disease in children with a Wilms' tumor.
    Jonge Poerink-Stockschlader AB; Dekker I; Risseeuw-Appel IM; Hählen K
    Med Pediatr Oncol; 1996 Apr; 26(4):238-43. PubMed ID: 8600334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The factor VIII complex: structure and function.
    Hoyer LW
    Prog Clin Biol Res; 1981; 72():1-26. PubMed ID: 6801681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Von Willebrand factor activity and thrombophilic states. A review (author's transl)].
    Boneu B; Abbal M; Barret A; Fournie A; Bierme R
    Pathol Biol (Paris); 1976 Dec; 24 Suppl():48-53. PubMed ID: 796810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of von Willebrand disease type 2N (Normandy) in Australia: a cross-laboratory investigation using different methods.
    Rodgers SE; Lerda NV; Favaloro EJ; Duncan EM; Casey GJ; Quinn DM; Hertzberg M; Lloyd JV
    Am J Clin Pathol; 2002 Aug; 118(2):269-76. PubMed ID: 12162689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The factor VIII/von Willebrand factor ratio discriminates between reduced synthesis and increased clearance of von Willebrand factor.
    Eikenboom JC; Castaman G; Kamphuisen PW; Rosendaal FR; Bertina RM
    Thromb Haemost; 2002 Feb; 87(2):252-7. PubMed ID: 11859851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of continuous infusion of a combined factor VIII-von Willebrand factor (vWF) concentrate (Haemate-P) in patients with von Willebrand disease.
    Lubetsky A; Schulman S; Varon D; Martinowitz U; Kenet G; Gitel S; Inbal A
    Thromb Haemost; 1999 Feb; 81(2):229-33. PubMed ID: 10063997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cold-dependent loss of factor VIII von Willebrand factor activities in citrated whole blood is reversed by rewarming.
    Refaai MA; Lukoszyk M; Hughes J; Eby CS; Van Cott EM
    Am J Clin Pathol; 2005 Dec; 124(6):972; author reply 973. PubMed ID: 16416745
    [No Abstract]   [Full Text] [Related]  

  • 19. [Molecular complex of factor VIII (antihemophilic factor) in hepatopathies].
    Vicente V; Batlle J; López Borrasca A
    Rev Esp Enferm Apar Dig; 1979 Mar; 55(3):279-90. PubMed ID: 472427
    [No Abstract]   [Full Text] [Related]  

  • 20. No influence of blood group on the responsiveness to desmopressin in type I "platelet normal" von Willebrand's disease.
    Castaman G; Rodeghiero F
    Thromb Haemost; 1995 Mar; 73(3):551-2. PubMed ID: 7667843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.